The cost-effectiveness of liver biopsy in rheumatoid arthritis patients treated with methotrexate.

@article{Bergquist1995TheCO,
  title={The cost-effectiveness of liver biopsy in rheumatoid arthritis patients treated with methotrexate.},
  author={S R Bergquist and David T. Felson and Mark J. Prashker and Kenneth A. Freedberg},
  journal={Arthritis and rheumatism},
  year={1995},
  volume={38 3},
  pages={326-33}
}
OBJECTIVE To assess the cost-effectiveness of liver biopsy in monitoring rheumatoid arthritis (RA) patients for methotrexate (MTX)-induced cirrhosis. METHODS A decision analytic model was used to compare a strategy of no biopsy versus strategies of biopsy after 5 years or 10 years of MTX treatment. RESULTS Biopsy after 5 years of MTX treatment had a… CONTINUE READING